191 related articles for article (PubMed ID: 7532709)
1. Effect of granulocyte colony-stimulating factor on preeclampsia-associated neonatal neutropenia.
La Gamma EF; Alpan O; Kocherlakota P
J Pediatr; 1995 Mar; 126(3):457-9. PubMed ID: 7532709
[TBL] [Abstract][Full Text] [Related]
2. Administration of granulocyte colony-stimulating factor to neutropenic low birth weight infants of mothers with preeclampsia.
Makhlouf RA; Doron MW; Bose CL; Price WA; Stiles AD
J Pediatr; 1995 Mar; 126(3):454-6. PubMed ID: 7532708
[TBL] [Abstract][Full Text] [Related]
3. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
[TBL] [Abstract][Full Text] [Related]
4. Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor effect in neutropenic neonates with suspected sepsis.
Zuppa AA; Girlando P; Florio MG; Cota F; Romagnoli C; Tortorolo G
Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):131-6. PubMed ID: 11950479
[TBL] [Abstract][Full Text] [Related]
5. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.
Roberts RL; Szelc CM; Scates SM; Boyd MT; Soderstrom KM; Davis MW; Glaspy JA
Am J Dis Child; 1991 Jul; 145(7):808-12. PubMed ID: 1711773
[TBL] [Abstract][Full Text] [Related]
6. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
7. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended?
Del Vecchio A; Christensen RD
Early Hum Dev; 2012 May; 88 Suppl 2():S19-24. PubMed ID: 22633505
[TBL] [Abstract][Full Text] [Related]
8. Transient effect of granulocyte colony-stimulating factor in allo-immune neonatal neutropenia.
Girlando P; Zuppa AA; Romagnoli C; Tortorolo G
Biol Neonate; 2000 Nov; 78(4):277-80. PubMed ID: 11093006
[TBL] [Abstract][Full Text] [Related]
9. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates.
Ahmad M; Fleit HB; Golightly MG; La Gamma EF
Biol Neonate; 2004; 86(1):48-54. PubMed ID: 15057022
[TBL] [Abstract][Full Text] [Related]
10. Neutropenia complicating Rh-hydrops fetalis: the effect of treatment with recombinant human granulocyte colony-stimulating factor (rhG-CSF).
Segal N; Leibovitz E; Juster-Reicher A; Even-Tov S; Mogilner B; Barak Y
Pediatr Hematol Oncol; 1998; 15(2):193-7. PubMed ID: 9592847
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony stimulating factor treatment for neonatal neutropenia.
Russell AR; Davies EG; Ball SE; Gordon-Smith E
Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F53-4. PubMed ID: 7538031
[TBL] [Abstract][Full Text] [Related]
13. Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery.
Calhoun DA; Rosa C; Christensen RD
Am J Obstet Gynecol; 1996 Apr; 174(4):1306-11. PubMed ID: 8623861
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human granulocyte colony-stimulating factor therapy for cyclic neutropenia associated with common variable immunodeficiency.
Tsuda M; Urakami T; Watanabe S; Shimizu H; Inana I; Kikkawa Y; Kitagawa T
Acta Paediatr Jpn; 1993 Apr; 35(2):124-6. PubMed ID: 7684881
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor.
Calhoun DA; Lunøe M; Du Y; Hutson AD; Veerman M; Christensen RD
Pediatrics; 2000 Feb; 105(2):392-7. PubMed ID: 10654961
[TBL] [Abstract][Full Text] [Related]
16. [Hematological effect of 14 days treatment of recombinant human granulocyte colony-stimulating factor for neutropenia in myelodysplastic syndromes].
Yoshida Y; Hirashima K; Asano S; Takaku F; Furusawa S; Ogawa T; Arimori S; Abe T; Suzuki T; Kato Y
Rinsho Ketsueki; 1991 Jul; 32(7):743-50. PubMed ID: 1717726
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of recombinant human granulocyte colony stimulating factor in very-low-birth-weight infants with early neutropenia.
Teng RJ; Wu TJ; Sharma R; Garrison RD; Hudak ML
J Formos Med Assoc; 2015 Feb; 114(2):174-9. PubMed ID: 25678180
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
[TBL] [Abstract][Full Text] [Related]
19. Cyclic neutropenia: natural history and effects of long-term treatment with recombinant human granulocyte colony-stimulating factor.
Dale DC; Bolyard AA; Hammond WP
Cancer Invest; 1993; 11(2):219-23. PubMed ID: 7681723
[No Abstract] [Full Text] [Related]
20. Treatment of alloimmune neonatal neutropenia with granulocyte colony-stimulating factor.
Gilmore MM; Stroncek DF; Korones DN
J Pediatr; 1994 Dec; 125(6 Pt 1):948-51. PubMed ID: 7527850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
